AnnotSV_ID	SV_chrom	SV_start	SV_end	SV_length	SV_type	Samples_ID	Annotation_mode	Gene_name	Gene_count	Tx	Tx_start	Tx_end	Overlapped_tx_length	Overlapped_CDS_length	Overlapped_CDS_percent	Frameshift	Exon_count	Location	Location2	Dist_nearest_SS	Nearest_SS_type	Intersect_start	Intersect_end	RE_gene	P_gain_phen	P_gain_hpo	P_gain_source	P_gain_coord	P_loss_phen	P_loss_hpo	P_loss_source	P_loss_coord	P_ins_phen	P_ins_hpo	P_ins_source	P_ins_coord	P_snvindel_nb	P_snvindel_phen	B_gain_source	B_gain_coord	B_gain_AFmax	B_loss_source	B_loss_coord	B_loss_AFmax	B_ins_source	B_ins_coord	B_ins_AFmax	B_inv_source	B_inv_coord	B_inv_AFmax	TAD_coordinate	ENCODE_experiment	GC_content_left	GC_content_right	Repeat_coord_left	Repeat_type_left	Repeat_coord_right	Repeat_type_right	Gap_left	Gap_right	SegDup_left	SegDup_right	ENCODE_blacklist_left	ENCODE_blacklist_characteristics_left	ENCODE_blacklist_right	ENCODE_blacklist_characteristics_right	ACMG	HI	TS	DDD_HI_percent	DDD_status	DDD_mode	DDD_consequence	DDD_disease	DDD_pmid	ExAC_delZ	ExAC_dupZ	ExAC_cnvZ	ExAC_synZ	ExAC_misZ	OMIM_ID	OMIM_phenotype	OMIM_inheritance	OMIM_morbid	OMIM_morbid_candidate	LOEUF_bin	GnomAD_pLI	ExAC_pLI	AnnotSV_ranking_score	AnnotSV_ranking_criteria	ACMG_class
22_18900627_18923913_DUP_1	22	18900627	18923913	23286	DUP	SGT196290	full	DGCR6;LOC102724770;LOC102724788;PRODH	4															PEX26 (morbid/RE=EA_enhancer);SLC25A1 (morbid/RE=EA_enhancer);TUBA8 (morbid/RE=EA_enhancer);USP18 (morbid/RE=EA_enhancer)													1	Inborn_genetic_diseases	18938887;19007340;19018612;19024864	DDD:56146;DDD:56173;DDD:56174;gnomAD-SV_v2.1_DUP_22_50647								20367739;21327625	IMH;IMH				0.670	0.590	22:18900035-18900952	SVA_D	22:18923926-18924145	AluJr			22:18774318-18939750;22:18872847-18902002;22:18896092-18902002	22:18774318-18939750;22:18901997-18924717	22:18175900-18947300	High Signal Region	22:18175900-18947300	High Signal Region				61.1									0.360135634788785	0.772811927860626	606810			yes	yes		9.8176e-12	4.7536e-06	0.0	1A (+0.00);2E (cf B_gain_source, +0.00);3A (4 genes, +0.00);5F (+0.00)	3
22_18900627_18923913_DUP_1	22	18900627	18923913	23286	DUP	SGT196290	split	DGCR6		NM_005675	18906319	18912088	5769	663	100	no	5	txStart-txEnd	5'UTR-3'UTR			18906319	18912088																18938887;19007340;19018612;19024864	DDD:56146;DDD:56173;DDD:56174;gnomAD-SV_v2.1_DUP_22_50647								20367739;21327625	IMH;IMH																					61.1									-0.678746019468492	-0.22775445384527						9	9.8176e-12	7.6210e-07			full=3
22_18900627_18923913_DUP_1	22	18900627	18923913	23286	DUP	SGT196290	split	LOC102724770		NM_001368242	18906319	18912088	5769	663	100	no	5	txStart-txEnd	5'UTR-3'UTR			18906319	18912088																18938887;19007340;19018612;19024864	DDD:56146;DDD:56173;DDD:56174;gnomAD-SV_v2.1_DUP_22_50647								20367739;21327625	IMH;IMH																																										full=3
22_18900627_18923913_DUP_1	22	18900627	18923913	23286	DUP	SGT196290	split	LOC102724788		NM_001368250	18912692	18936293	11221	1136	76	yes	14	intron4-txEnd	CDS-3'UTR	734	3'	18912692	18923913														1	Inborn_genetic_diseases	18938887;19007340;19018612;19024864	DDD:56146;DDD:56173;DDD:56174;gnomAD-SV_v2.1_DUP_22_50647								20367739;21327625	IMH;IMH																																										full=3
22_18900627_18923913_DUP_1	22	18900627	18923913	23286	DUP	SGT196290	split	PRODH		NM_016335	18912780	18936293	11133	1136	63	yes	14	intron4-txEnd	CDS-3'UTR	734	3'	18912780	18923913														1	Inborn_genetic_diseases	18938887;19007340;19018612;19024864	DDD:56146;DDD:56173;DDD:56174;gnomAD-SV_v2.1_DUP_22_50647								20367739;21327625	IMH;IMH																					45.38									0.360135634788785	0.772811927860626	606810	Hyperprolinemia, type I, 239500 (3);(Schizophrenia, susceptibility to, 4), 600850 (3)	AD;AR	yes	yes	6	5.3577e-12	4.7536e-06			full=3
7_147182966_147183193_DUP_1	7	147182966	147183193	227	DUP	SGT156058	full	CNTNAP2	1																																							154127681	IMH				0.250	0.270														1		4.94						0.563947177367305	0.204322538168797	0.472669462802937	-0.110048241311169	-0.708639484822799	604569			yes	yes		2.8673e-09	3.8288e-05	0.0	1A (+0.00);2I-3 (CNTNAP2, +0.00);3A (1 gene, +0.00);5F (+0.00)	3
7_147182966_147183193_DUP_1	7	147182966	147183193	227	DUP	SGT156058	split	CNTNAP2		NM_014141	146774270	148420996	227	0	0	no	23	intron7-intron7	CDS	50457	5'	147182966	147183193																									154127681	IMH																			1	0	4.94	confirmed	biallelic	loss of function	CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME	11568923;19896112;16571880	0.563947177367305	0.204322538168797	0.472669462802937	-0.110048241311169	-0.708639484822799	604569	Cortical dysplasia-focal epilepsy syndrome, 610042 (3);Pitt-Hopkins like syndrome 1, 610042 (3);(Autism susceptibility 15), 612100 (3)	AR	yes	yes	2	2.8673e-09	3.8288e-05			full=3
7_74166361_74173228_DEL_1	7	74166361	74173228	-6867	DEL	ACE2105804	full		0																																							100351151;101265654;101265940;102378889;102379805;105619581;75471101;98454729	IMH;IMH;IMH;IMH;IMH;IMH;IMH;IMH				0.490	0.505	7:74166259-74166617	THE1B	7:74172989-74173266;7:74173266-74173447	AluSg;AluJr																															-0.6	1B (-0.60);3A (0 gene, +0.00);5F (+0.00)	3
11_654497_654778_DEL_1	11	654497	654778	-281	DEL	SGT167482	full	DEAF1	1															CD151 (morbid/RE=EA_enhancer);DRD4 (morbid/RE=EA_enhancer);EPS8L2 (morbid/RE=EA_enhancer);HRAS (morbid/RE=EA_enhancer);IFITM5 (morbid/RE=EA_enhancer);LRRC56 (morbid/RE=EA_enhancer);PNPLA2 (morbid/RE=EA_enhancer);SCT (morbid/RE=EA_enhancer);SLC25A22 (morbid/RE=EA_enhancer);TALDO1 (morbid/RE=EA_enhancer)																		655159;655178	gnomAD-SV_v2.1_DEL_11_115643;gnomAD-SV_v2.1_DEL_11_115644;DDD:34726;IMH;1000g										0.585	0.525	11:654165-654463;11:654592-654884	AluSg7;AluSx1	11:654592-654884	AluSx1												76.16						-1.40912503889153	-0.66364556021033	-0.9781174835276	0.979121602654753	2.86731925032015	602635			yes			3.4113e-04	1.9316e-04	-1.0	1A (+0.00);2F (cf B_loss_source, -1.00);3A (1 gene, +0.00);5F (+0.00)	1
11_654497_654778_DEL_1	11	654497	654778	-281	DEL	SGT167482	split	DEAF1		NM_001293634	644219	695754	281	42	2	no	11	intron8-intron9	CDS	117	5'	654497	654778																			655159;655178	gnomAD-SV_v2.1_DEL_11_115643;gnomAD-SV_v2.1_DEL_11_115644;DDD:34726;IMH;1000g																											76.16	confirmed;probable	biallelic;monoallelic	dominant negative;loss of function	Autism, intellectual disability, basal ganglia dysfunction and epilepsy;MENTAL RETARDATION, AUTOSOMAL DOMINANT 24	24726472;21076407;26834045;26048982	-1.40912503889153	-0.66364556021033	-0.9781174835276	0.979121602654753	2.86731925032015	602635	Neurodevelopmental disorder with hypotonia, impaired expressive language, and with or without seizures, 617171 (3);Vulto-van Silfout-de Vries syndrome, 615828 (3)	AD;AR	yes		3	3.4113e-04	1.9316e-04			full=1
